LABORATORY CRP OF AMER HLDGS (LH)

US50540R4092 - Common Stock

218.46  +1.89 (+0.87%)

After market: 218.46 0 (0%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to LH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 251.94. This target is 15.33% above the current price.
LH was analyzed by 26 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LH.
In the previous month the buy percentage consensus was at a similar level.
LH was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 218.46222.20249.90251.94283.50 - 1.71% 14.39% 15.33% 29.77%
Up and Down Grades
Date Firm Action Rating
2024-03-25 Argus Research Upgrade Hold -> Buy
2024-02-26 Leerink Partners Initiate Outperform
2024-02-09 Evercore ISI Group Initiate In-Line
2024-01-03 Barclays Initiate Equal-Weight
2023-11-17 JP Morgan Maintains Overweight -> Overweight
2023-10-31 Mizuho Maintains Buy -> Buy
2023-09-21 B of A Securities Maintains Buy -> Buy
2023-09-18 Baird Maintains Outperform -> Outperform
2023-09-15 Mizuho Reiterate Buy -> Buy
2023-09-15 Truist Securities Reiterate Buy -> Buy
2023-09-06 HSBC Initiate Hold
2023-08-14 Wells Fargo Maintains Overweight -> Overweight
2023-08-03 Morgan Stanley Maintains Overweight -> Overweight
2023-08-02 Credit Suisse Maintains Outperform -> Outperform
2023-07-31 Baird Maintains Outperform -> Outperform
2023-07-28 Truist Securities Maintains Buy -> Buy
2023-06-05 Credit Suisse Reiterate Outperform -> Outperform
2023-05-16 Mizuho Maintains Buy -> Buy
2023-05-10 Morgan Stanley Maintains Overweight
2023-05-01 Truist Securities Maintains Buy
2023-03-13 Credit Suisse Maintains Outperform
2023-02-21 Wells Fargo Maintains Overweight
2023-02-21 Credit Suisse Maintains Outperform
2023-02-17 Mizuho Maintains Buy
2023-02-17 Truist Securities Maintains Buy
2023-02-17 Baird Maintains Outperform
2023-02-17 Citigroup Maintains Neutral
2023-01-11 Baird Maintains Outperform
2023-01-06 Morgan Stanley Maintains Overweight
2022-12-12 Citigroup Downgrade Buy -> Neutral